ArticleScientific reports2026
SkinFormer: a hybrid vision transformer and ConvNeXtV2 approach for skin cancer detection and segmentation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer remains one of the most prevalent and deadly forms of cancer globally, where early detection plays a critical role in improving survival rates. In this study, we introduce SkinFormer, a novel hybrid deep learning architecture primarily designed for binary skin lesion classification (benign vs. malignant), enhanced by a standalone pretrained segmentation module for accurate ROI cropping. It incorporates Vision Transformers (ViT), ConvNeXtV2, and a Separable Self-Attention method to improve the precision and interpretability of skin lesion classification and segmentation. Utilizing a portion of the ISIC 2024 dataset alongside the DermQuest dataset, which includes more than 55,000 images for binary classification of benign and malignant skin lesions, SkinFormer attains promising performance with an accuracy of 96.8%, an AUC of 0.985, and an F1-score of 95.8%. The independent segmentation module attains a Dice Similarity Coefficient of 95.6% and an Intersection over Union of 91.8%. The approach effectively resolves issues including irregular lesion borders, low contrast, and artifacts through the integration of global contextual reasoning and local texture extraction. Ablation experiments validate the importance of each architectural module, while qualitative heatmaps and overlay visualizations enhance its clinical interpretability. Statistical significance was established by McNemar’s test (p < 0.01), underscoring the method’s resilience. The results indicate that SkinFormer is a potential instrument for automated skin cancer diagnosis, a potential tool for clinical decision support and teledermatology applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.